Chancellor Rachel Reeves Aims for Targeted Action on Household Expenses in Forthcoming Budget
Chancellor Rachel Reeves has announced she is preparing "focused steps to address household expense challenges" in the upcoming financial statement.
During an interview with the BBC, she noted that curbing inflation is a joint responsibility of both the government and the central bank.
The United Kingdom's price growth is projected to be the highest among the Group of Seven industrialized countries this calendar year and the following year.
Potential Energy Bill Interventions
Reports indicate the administration could intervene to reduce utility costs, such as by slashing the current 5% level of VAT charged on energy supplies.
Another approach is to cut some of the regulatory levies presently added to household expenses.
Fiscal Constraints and Expert Expectations
The administration will receive the latest draft from the official forecaster, the OBR, on the start of the week, which will clarify how much room there is for these actions.
The view from the majority of economists is that Reeves will have to introduce higher taxes or expenditure reductions in order to fulfill her declared borrowing rules.
Previously on the same day, analysis suggested there was a £22bn deficit for the chancellor to address, which is at the lower end of expectations.
"It is a collective responsibility between the Bank of England and the government to further reduce some of the causes of inflation," Reeves told reporters in the US capital, at the conferences of the International Monetary Fund and World Bank.
Revenue Pledges and Global Concerns
While much of the attention has been on expected tax rises, the Treasury chief said the most recent data from the OBR had not changed her pledge to election pledges not to raise rates on earnings tax, sales tax or social security contributions.
She attributed an "uncertain global environment" with rising geopolitical and commercial tensions for the Budget revenue measures, likely to be directed on those "with the broadest shoulders."
Global Economic Tensions
Referring to apprehensions about the United Kingdom's economic relations with the Asian nation she said: "The UK's national security always come first."
Recent announcement by China to tighten trade restrictions on critical minerals and other resources that are essential for high-technology manufacturing led American leader the US President to propose an further 100% tariff on goods from China, raising the risk of an all-out commercial conflict between the two economic giants.
The American finance chief described the Chinese decision "commercial pressure" and "a global supply chain power grab."
Questioned on considering the US offer to join its battle with the Asian nation, Reeves said she was "very concerned" by Chinese measures and urged the Beijing authorities "to avoid restrictions and limit trade."
She said the move was "bad for the international commerce and generates further headwinds."
"I believe there are fields where we should challenge China, but there are also valuable chances to export to Chinese markets, including banking sector and other areas of the economy. We've got to maintain that equilibrium appropriate."
The chancellor also stated she was collaborating with other major economies "regarding our own essential resources plan, so that we are less reliant."
Health Service Medicine Costs and Investment
The Chancellor also admitted that the price the National Health Service pays for medicines could increase as a consequence of ongoing negotiations with the Trump administration and its pharmaceutical firms, in return for reduced taxes and funding.
Some of the world's largest drug companies have said recently that they are either halting or canceling projects in the UK, with some attributing the low prices they are getting.
Last month, the Science Minister said the cost the NHS spends on medicines would must rise to halt firms and drug research funding leaving the UK.
The Chancellor informed the BBC: "We have seen because of the payment system, that clinical trials, innovative medicines have not been provided in the UK in the manner that they are in other continental states."
"We want to make sure that patients getting care from the National Health Service are can obtain the finest essential medicines in the globe. And so we are examining these issues, and... seeking to obtain more capital into the UK."